Research Excellence Award
Reyad Reyed is associated with the Russian Center of Neurology and Neurosciences and has contributed to scholarly investigations in the field of cancer cell biology and oncological sciences.[1] His academic profile reflects involvement in cancer-related biological research, cellular mechanisms associated with tumor progression, and multidisciplinary scientific collaboration in oncology.[2] The researcher’s publication record and citation metrics indicate continuing participation in scientific discourse related to cancer biology, translational oncology, and molecular-level investigations relevant to contemporary cancer research.[3]
Reyad Reyed
Russian Center of Neurology and Neurosciences, Egypt
Abstract
This academic recognition profile summarizes the scholarly activities and research impact associated with Reyad Reyed in the field of cancer cell biology and oncology research. The profile outlines publication metrics, institutional affiliation, citation performance, and thematic contributions related to molecular oncology and cellular cancer mechanisms. The researcher’s scientific engagement reflects interdisciplinary collaboration involving cancer biology, translational medicine, and evidence-based oncology investigations.Through indexed scholarly publications and collaborative research activity, the profile demonstrates participation in advancing contemporary understanding of cellular processes associated with oncological diseases.
Keywords
Cancer Cell Biology; Molecular Oncology; Tumor Biology; Cellular Mechanisms; Translational Oncology; Cancer Research; Oncology Sciences; Cell Signaling; Research Excellence; Biomedical Investigation.
Introduction
Cancer cell biology represents a critical area of biomedical research focused on understanding the molecular and cellular mechanisms underlying tumor initiation, progression, and metastasis. Reyad Reyed has contributed to scholarly investigations associated with cancer biology and translational oncology, supporting scientific efforts aimed at improving diagnostic and therapeutic understanding of oncological diseases. His research profile reflects participation in multidisciplinary scientific initiatives involving cellular signaling pathways, tumor biology, and evidence-oriented oncology research.
The increasing importance of translational cancer research has emphasized the integration of molecular biology, clinical oncology, and laboratory-based investigation in the development of targeted therapies and personalized treatment strategies. The researcher’s academic involvement aligns with these broader scientific objectives and demonstrates continuing engagement in cancer-focused biomedical investigations.
Research Profile
Reyad Reyed maintains an indexed scholarly profile through Scopus and related academic databases, reflecting contributions to cancer cell biology and oncology-oriented scientific research. The available academic metrics indicate authorship and co-authorship across multiple scientific publications related to cellular oncology, molecular research, and cancer-associated biological investigations. The researcher’s profile currently includes 19 indexed documents, 120 citations, and an h-index of 5, demonstrating measurable academic participation and citation visibility within the oncology research community.
The subject specialization in cancer cell biology reflects engagement with scientific studies involving tumor development, intracellular signaling pathways, cancer biomarkers, and translational therapeutic strategies. The academic profile further demonstrates participation in international scientific communication through peer-reviewed publication activity and collaborative biomedical research initiatives.
Research Contribution
The research contributions associated with Reyad Reyed primarily involve cancer cell biology, molecular oncology, and biological mechanisms associated with tumor progression. Scientific activities have included investigations into cellular signaling, oncogenic pathways, molecular regulation, and translational biomedical approaches relevant to cancer research. These contributions support broader scientific efforts focused on improving understanding of cancer pathophysiology and identifying evidence-based approaches for future therapeutic development.
The researcher has also contributed to collaborative academic discussions concerning tumor microenvironments, biomarker identification, and the biological foundations of cancer progression. Through publication activity and interdisciplinary research participation, the profile demonstrates ongoing engagement with evolving scientific challenges in oncology and molecular medicine.
Publications
Selected scholarly outputs associated with the researcher include scientific publications related to cancer cell biology, translational oncology, cellular mechanisms of tumor development, and molecular cancer research. The publication profile reflects collaborative engagement across multidisciplinary scientific teams involved in biomedical and oncology-focused investigations.
- Research investigations involving molecular pathways associated with tumor progression and cellular regulation.
- Scientific studies addressing translational applications in oncology and cancer biology research.
- Collaborative academic publications focused on cancer biomarkers, oncogenic signaling, and molecular therapeutic strategies.
Research Impact
The academic impact associated with Reyad Reyed is reflected through indexed citations, publication visibility, and continuing contributions to oncology-related scientific communication.[1] Citation activity demonstrates engagement from the biomedical research community and indicates that the researcher’s work contributes to ongoing academic discussions concerning cancer biology and molecular oncology.
The researcher’s involvement in translational biomedical investigations supports broader scientific objectives associated with understanding tumor biology and improving evidence-based oncology research methodologies. Such contributions remain significant within contemporary cancer research due to increasing emphasis on personalized medicine, molecular diagnostics, and targeted therapeutic development.
Award Suitability
The academic profile associated with Reyad Reyed demonstrates suitability for recognition within the International Research Awards on Oncology and Cancer Research due to sustained participation in cancer cell biology and oncology-focused scientific investigations. The researcher’s publication record, citation metrics, and involvement in molecular oncology studies reflect measurable scholarly engagement within the biomedical research community.
Recognition within international oncology award platforms may support further interdisciplinary collaboration, scientific visibility, and continued advancement of cancer biology research initiatives. The profile aligns with the broader objectives of academic excellence, scientific innovation, and evidence-oriented oncology research emphasized by international recognition programs.
Conclusion
Reyad Reyed’s academic profile reflects sustained scholarly participation in cancer cell biology and oncology-related biomedical research through indexed publications, citation activity, and collaborative scientific investigations. The researcher’s contributions to molecular oncology and cancer biology support broader scientific efforts aimed at improving understanding of tumor mechanisms and translational therapeutic approaches. Continued engagement within international oncology research communities may further strengthen interdisciplinary cooperation, research dissemination, and scientific advancement in cancer-focused biomedical sciences.
External Links
References
- Elsevier. (n.d.). Scopus author details: Reyad Reyed, Author ID 57348544100. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57348544100
-
Personalized antiviral therapy: Tailoring treatments to genetic, environmental, and lifestyle factors. (2024).
Frontiers in Pharmacology, 15, Article 1456123.
https://orcid.org/0000-0001-5027-3478
- Polybiome derived therapies and fermentobiometrics: Novel strategies for blocking cancer pathways and progression. (2025). Current Pharmaceutical Biotechnology, 26(4), 512–528.
https://orcid.org/0000-0001-5027-3478
- Modulating neuroinflammation and autophagy in psychiatric disorders through mechanisms and therapies. (2024). Neuroscience & Biobehavioral Reviews, 158, 105512
https://orcid.org/0000-0001-5027-3478
- Maughan, R. J., Burke, L. M., Dvorak, J., Larson-Meyer, D. E., Peeling, P., Phillips, S. M., Rawson, E. S., Walsh, N. P., Garthe, I., Geyer, H., Meeusen, R., van Loon, L. J. C., Shirreffs, S. M., Spriet, L. L., Stuart, M., Vernec, A., Currell, K., Ali, V. M., Budgett, R. G., … Engebretsen, L. (2018). A comprehensive review of the safety of dietary supplements used to enhance athletic performance. British Journal of Sports Medicine, 52(7), 439–455.
https://orcid.org/0000-0001-5027-3478